MLchartDataset catalogue

yttrium Y 90-DOTA monoclonal antibody HuPAM4

Term · Oncology and biomedicine · MLC-T-ONC-009448

A substance being studied in the treatment of advanced pancreatic cancer. Yttrium Y 90-DOTA monoclonal antibody HuPAM4 contains a monoclonal antibody that binds to a protein called MUC-1, which is found on some pancreatic cancer cells. It also contains a radioactive substance called yttrium Y 90, which may help kill cancer cells. Yttrium Y 90-DOTA monoclonal antibody HuPAM4 is a type of radioimmunoconjugate. Also called yttrium Y 90-clivatuzumab tetraxetan.

Table 1. Record
IdentifierMLC-T-ONC-009448
FieldOncology and biomedicine
Synonymsyttrium Y 90-clivatuzumab tetraxetan
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-009448",
  "term": "yttrium Y 90-DOTA monoclonal antibody HuPAM4",
  "field": "Oncology and biomedicine",
  "definition": "A substance being studied in the treatment of advanced pancreatic cancer. Yttrium Y 90-DOTA monoclonal antibody HuPAM4 contains a monoclonal antibody that binds to a protein called MUC-1, which is found on some pancreatic cancer cells. It also contains a radioactive substance called yttrium Y 90, which may help kill cancer cells. Yttrium Y 90-DOTA monoclonal antibody HuPAM4 is a type of radioimmunoconjugate. Also called yttrium Y 90-clivatuzumab tetraxetan.",
  "synonyms": [
    "yttrium Y 90-clivatuzumab tetraxetan"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/yttrium-y-90-dota-monoclonal-antibody-hupam4/"
}

Record 17,578 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.